Streptomyces spectabilis

Streptomyces spectabilis
Scientific classification Edit this classification
Domain: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Streptomycetales
Family: Streptomycetaceae
Genus: Streptomyces
Species:
S. spectabilis
Binomial name
Streptomyces spectabilis
Mason et al. 1961[1]
Type strain
ATCC 27465, BCRC 12648, CBS 725.72, CBS 725.75, CCRC 12648, CECT 3146, CECT 3156, DSM 40512, DSMZ 40512, IFO 13424, IFO 15441, ISP 5512, JCM 4308, JCM 4832, KCC S-0308, KCC S-0832, KCCS-0308, KCCS-0832, KCTC 9218, LMG 5986, MR ISP-5512, NBIMCC 70, NBRC 13424, NBRC 15441, NCAIM B.01936, NCIB 9733, NCIMB 9733, NRRL 2494, NRRL B-2494, NRRL-ISP 5512, RIA 1385[2]

Streptomyces spectabilis is a bacterium species from the genus of Streptomyces.[1][3][4] Streptomyces spectabilis produces hangtaimycin, gentamicin, kanamycin, neomycin B, sisomycin, tobramycin, paromomycin, spectinabilin, spectinomycin, aminocyclitol, actinospectacin, prodigiosine and the streptovaricin complex.[4][5][6][7][8][9][10]

Further reading

  • Kim, Kyoung-Rok; Kim, Tae-Jong; Suh, Joo-Won (29 July 2008). "The Gene Cluster for Spectinomycin Biosynthesis and the Aminoglycoside-Resistance Function of spcM in Streptomyces spectabilis". Current Microbiology. 57 (4): 371–374. doi:10.1007/s00284-008-9204-y. PMID 18663525. S2CID 35278973.
  • Isaka, M.; Jaturapat, A.; Kramyu, J.; Tanticharoen, M.; Thebtaranonth, Y. (1 April 2002). "Potent In Vitro Antimalarial Activity of Metacycloprodigiosin Isolated from Streptomycesspectabilis BCC 4785". Antimicrobial Agents and Chemotherapy. 46 (4): 1112–1113. doi:10.1128/AAC.46.4.1112-1113.2002. PMC 127104. PMID 11897600.
  • HOEKSEMA, HERMAN; KNIGHT, JOHN C. (1975). "The production of dihydrospectinomycin by Syreptomyces spect abilis". The Journal of Antibiotics. 28 (3): 240–241. doi:10.7164/antibiotics.28.240. PMID 123898.
  • Selvakumar, JN; Chandrasekaran, SD; Vaithilingam, M (October 2015). "Bio Prospecting of Marine-derived Streptomyces spectabilis VITJS10 and Exploring its Cytotoxicity Against Human Liver Cancer Cell Lines". Pharmacognosy Magazine. 11 (Suppl 3): S469–73. doi:10.4103/0973-1296.168974. PMC 4745219. PMID 26929583.
  • Staley, AL; Rinehart, KL (December 1994). "Spectomycins, new antibacterial compounds produced by Streptomyces spectabilis: isolation, structures, and biosynthesis". The Journal of Antibiotics. 47 (12): 1425–33. doi:10.7164/antibiotics.47.1425. PMID 7844036.
  • Atta-ur-Rahman, edited by (2000). Bioactive natural products. Amsterdam: Elsevier. ISBN 978-0-08-054202-7. {{cite book}}: |first1= has generic name (help)
  • ed.-in-chief, George M. Garrity (2012). Bergey's manual of systematic bacteriology (2nd ed.). New York: Springer Science + Business Media. ISBN 978-0-387-68233-4. {{cite book}}: |last1= has generic name (help)
  • Arya, Dev P. (2007). Aminoglycoside antibiotics from chemical biology to drug discovery. Hoboken, N.J.: Wiley-Interscience. ISBN 978-0-470-14966-9.
  • Brossi, Arnold, ed. (1985). The alkaloids chemistry and pharmacology. Orlando: Academic Press. ISBN 978-0-08-086549-2.
  • Corcoran, John W., ed. (1981). Biosynthesis. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 978-3-642-67724-3.
  • Stephen W., Queener (1986). Antibiotic- Producing Stetomyces. Oxford: Elsevier Science. ISBN 978-0-323-16293-7.

See also

References

  1. ^ a b LPSN bacterio.net
  2. ^ Straininfo of Streptomyces spectabilis
  3. ^ UniProt
  4. ^ a b Deutsche Sammlung von Mikroorganismen und Zellkulturen [1]
  5. ^ Kakinuma, K.; Hanson, C.A.; Rinehart, K.L. (January 1976). "Spectinabilin, a new nitro-containing metabolite isolated from streptomyces spectabilis". Tetrahedron. 32 (2): 217–222. doi:10.1016/0040-4020(76)87004-4.
  6. ^ editors, Satinder Kaur Brar, Gurpreet Singh Dhillon, Carlos Ricardo Soccol (2014). Biotransformation of Waste Biomass into High Value Biochemicals. New York, NY: Springer New York. ISBN 978-1-4614-8005-1. {{cite book}}: |last1= has generic name (help)CS1 maint: multiple names: authors list (link)
  7. ^ editors, Thomas J. Dougherty, Michael J. Pucci (2012). Antibiotic discovery and development (2012. ed.). New York: Springer. ISBN 978-1-4614-1400-1. {{cite book}}: |last1= has generic name (help)CS1 maint: multiple names: authors list (link)
  8. ^ Mordarski, edited by M. Goodfellow, S.T. Williams, M. (1988). Actinomycetes in Biotechnology. Oxford: Elsevier Science. ISBN 978-0-08-098433-9. {{cite book}}: |first1= has generic name (help)CS1 maint: multiple names: authors list (link)
  9. ^ J., Elks (1990). Dictionary of Drugs Chemical Data, Structures and Bibliographies. Boston, MA: Springer US. ISBN 978-1-4757-2085-3.
  10. ^ Zuo, Lijie; Jiang, Bingya; Jiang, Zhibo; Zhao, Wei; Li, Shufen; Liu, Hongyu; Hong, Bin; Yu, Liyan; Zuo, Limin; Wu, Linzhuan (9 March 2016). "Hangtaimycin, a peptide secondary metabolite discovered from Streptomyces spectabilis CPCC 200148 by chemical screening". The Journal of Antibiotics. 69 (11): 835–838. doi:10.1038/ja.2016.29. PMID 26956796. S2CID 22307941.


Stub icon

This Streptomyces-related article is a stub. You can help Wikipedia by expanding it.